Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $558.51 | 34 | 96.9% |
| Education | $17.84 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $170.66 | 12 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $64.04 | 4 | $0 (2020) |
| AbbVie, Inc. | $61.69 | 3 | $0 (2019) |
| GlaxoSmithKline, LLC. | $54.12 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $46.99 | 2 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $24.23 | 1 | $0 (2020) |
| SCILEX PHARMACEUTICALS INC. | $23.19 | 1 | $0 (2020) |
| Sanofi Pasteur Inc. | $21.97 | 1 | $0 (2018) |
| Amneal Pharmaceuticals LLC | $21.29 | 1 | $0 (2019) |
| Allergan Inc. | $18.13 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $78.04 | 4 | Sunovion Pharmaceuticals Inc. ($24.23) |
| 2019 | $138.78 | 8 | AstraZeneca Pharmaceuticals LP ($43.01) |
| 2018 | $206.96 | 12 | AstraZeneca Pharmaceuticals LP ($70.94) |
| 2017 | $152.57 | 11 | AstraZeneca Pharmaceuticals LP ($56.71) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiovascular | ||||||
| 11/12/2020 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: CNS | ||||||
| 03/06/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: VACCINE | ||||||
| 02/07/2020 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Analgesic | ||||||
| 12/06/2019 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 07/19/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Endocrinology | ||||||
| 06/08/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2019 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), VARIVAX, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: VACCINE | ||||||
| 03/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: UROLOGY | ||||||
| 11/09/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: UROLOGY | ||||||
| 09/14/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $15.73 | General |
| 07/13/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $17.84 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 06/15/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Endocrinology | ||||||
| 05/25/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/13/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), ADACEL, NO PRODUCT DISCUSSED | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: VACCINES | ||||||
| 03/15/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Respiratory | ||||||
| 02/08/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2018 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2017 | GlaxoSmithKline, LLC. | BREO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 195 | 232 | $38,018 | $9,779 |
| 2022 | 9 | 245 | 299 | $44,026 | $12,994 |
| 2021 | 7 | 247 | 281 | $42,631 | $20,870 |
| 2020 | 8 | 276 | 314 | $44,271 | $18,051 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $11,800 | $2,877 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 71 | $10,650 | $2,502 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 37 | $8,300 | $1,646 | 19.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 19 | $1,900 | $1,315 | 69.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 18 | $3,828 | $795.30 | 20.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $640.00 | $501.92 | 78.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $900.00 | $141.12 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 89 | $13,350 | $3,738 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $11,050 | $2,662 | 24.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 26 | 29 | $2,950 | $2,462 | 83.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 18 | $5,466 | $1,360 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 27 | $6,075 | $1,121 | 18.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 13 | 14 | $1,050 | $563.05 | 53.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 14 | $560.00 | $429.78 | 76.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 21 | 21 | $2,100 | $403.94 | 19.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 17 | $1,275 | $201.46 | 15.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 15 | $150.00 | $51.54 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 53 | 53 | $10,600 | $7,311 | 69.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 96 | $14,400 | $6,566 | 45.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 20 | $4,500 | $1,949 | 43.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 19 | 21 | $2,100 | $1,322 | 62.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 12 | $1,500 | $1,233 | 82.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 22 | $4,106 | $1,229 | 29.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 46 | 46 | $4,600 | $899.30 | 19.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 11 | 11 | $825.00 | $360.48 | 43.7% |
About Leah Marano
Leah Marano is a Internal Medicine healthcare provider based in East Greenwich, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245456011.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leah Marano has received a total of $576.35 in payments from pharmaceutical and medical device companies, with $78.04 received in 2020. These payments were reported across 35 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($558.51).
As a Medicare-enrolled provider, Marano has provided services to 963 Medicare beneficiaries, totaling 1,126 services with total Medicare billing of $61,694. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location East Greenwich, RI
- Active Since 04/18/2007
- Last Updated 11/01/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1245456011
Products in Payments
- FARXIGA (Drug) $140.83
- Synthroid (Drug) $61.69
- MYRBETRIQ (Drug) $46.99
- BEVESPI AEROSPHERE (Drug) $29.83
- BREO (Drug) $25.68
- KYNMOBI (Drug) $24.23
- ZTLido (Drug) $23.19
- FLUZONE HIGH-DOSE (Drug) $21.97
- UNITHROID (Drug) $21.29
- LINZESS (Drug) $18.13
- INTRAROSA (Drug) $17.84
- BELSOMRA (Drug) $16.22
- ZOSTAVAX (Biological) $16.19
- PNEUMOVAX 23 (Biological) $15.90
- ADVAIR (Drug) $15.84
- Vascepa (Drug) $14.72
- Unithroid (Drug) $13.22
- IMVEXXY (Drug) $12.81
- ANORO (Drug) $12.60
- Osphena (Drug) $11.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Greenwich
Dr. David Fried, Md, MD
Internal Medicine — Payments: $248,518
Dr. Todd Viccione, Md, MD
Internal Medicine — Payments: $25,434
Dr. Jonathan Martin, M.d, M.D
Internal Medicine — Payments: $13,170
Dr. Richard Leach, Do, DO
Internal Medicine — Payments: $6,095
Dr. Shahid Khan, Md, MD
Internal Medicine — Payments: $4,742
Silvia Pena, Md, MD
Internal Medicine — Payments: $535.25